Debio 4228
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Debio 4228, covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer [Phase 2]